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The glucose metabolite methylglyoxal inhibits 
expression of the glucose transporter genes by 
inactivating the cell surface glucose sensors Rgt2 
and Snf3 in yeast
ABSTRACT Methylglyoxal (MG) is a cytotoxic by-product of glycolysis. MG has inhibitory ef-
fect on the growth of cells ranging from microorganisms to higher eukaryotes, but its mole-
cular targets are largely unknown. The yeast cell-surface glucose sensors Rgt2 and Snf3 func-
tion as glucose receptors that sense extracellular glucose and generate a signal for induction 
of expression of genes encoding glucose transporters (HXTs). Here we provide evidence that 
these glucose sensors are primary targets of MG in yeast. MG inhibits the growth of glucose-
fermenting yeast cells by inducing endocytosis and degradation of the glucose sensors. How-
ever, the glucose sensors with mutations at their putative ubiquitin-acceptor lysine residues 
are resistant to MG-induced degradation. These results suggest that the glucose sensors are 
inactivated through ubiquitin-mediated endocytosis and degraded in the presence of MG. In 
addition, the inhibitory effect of MG on the glucose sensors is greatly enhanced in cells lack-
ing Glo1, a key component of the MG detoxification system. Thus the stability of these glu-
cose sensors seems to be critically regulated by intracellular MG levels. Taken together, these 
findings suggest that MG attenuates glycolysis by promoting degradation of the cell-surface 
glucose sensors and thus identify MG as a potential glycolytic inhibitor.
INTRODUCTION
Methylglyoxal (MG) is a reactive dicarbonyl compound formed by 
nonenzymatic elimination of phosphate from the triose phosphates 
of glycolysis, dihydroxyacetone phosphate (DHAP) and glyceralde-
hyde-3-phosphate (G3P), in eukaryotic cells (Richard, 1984, 1993; 
Phillips and Thornalley, 1993), as well as enzymatically from DHAP in 
a reaction catalyzed by MG synthase in bacteria (Cooper and 
Anderson, 1970; Hopper and Cooper, 1972). Once formed, MG ir-
reversibly modifies amino groups of proteins, nucleic acids, and 
membrane lipids, forming advanced glycation end products 
(Thornalley, 1998), which are associated with various pathologies, 
including diabetes, aging-related disorders, and neurodegenerative 
diseases (Desai et al., 2010; Rabbani and Thornalley, 2011; Beiss-
wenger, 2014; Allaman et al., 2015). Cells are protected against 
methylglyoxal toxicity by the glyoxalase system, which is composed 
of two enzymes: glyoxalase I (Glo1), which metabolizes MG to S-d-
lactoylglutathione, and glyoxalase II (Glo2), which converts S-d-lact-
oylglutathione to d-lactate (Thornalley, 2003). MG appears to be the 
major physiological substrate for Glo1. Overexpression of Glo1 pre-
vents MG accumulation (Shinohara et al., 1998), whereas Glo1 inhi-
bition increases MG accumulation, decreasing cellular viability 
(Kuhla et al., 2006).
The budding yeast Saccharomyces cerevisiae prefers to ferment 
rather than oxidize glucose, even when oxygen is abundant—
so-called aerobic glycolysis (Crabtree, 1929; Warburg, 1956; 
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transporters, ∼17. Several of the glucose transporters are expressed 
only when glucose is available and only under the appropriate con-
ditions (Ozcan and Johnston, 1999). For example, the low-affinity 
glucose transporter Hxt1 is only expressed when glucose is abun-
dant, and the high-affinity glucose transporters Hxt2 and Hxt4 are 
expressed only when glucose is scarce. HXT3, which encodes a glu-
cose transporter of intermediate affinity, is expressed in cells ex-
posed to both low (0.2%) and high (2%) levels of glucose (Ozcan 
and Johnston, 1995). MG is a cytotoxic compound produced pri-
marily as a by-product of glycolysis (Figure 1A), but its molecular 
targets are largely unknown.
Raffinose is a trisaccharide consisting of fructose–glucose–galac-
tose and for S. cerevisiae is equivalent to low glucose because it can 
cleave the fructose–glucose bond only inefficiently and thus obtains 
only low levels of glucose from it (Ozcan and Johnston, 1999). To 
investigate the effect of MG on the viability of S. cerevisiae, we 
treated the yeast cells grown in medium containing glucose or raf-
finose with different concentrations of MG. The results showed that 
MG inhibits yeast cell growth in a dose-dependent manner, sug-
gesting the possibility of an inhibitory effect of MG on glucose utili-
zation (Figure 1B).
Next we examined directly the effect of MG on the expression of 
the glucose transporter genes by measuring mRNA levels of Hxt1, 
Hxt2, Hxt3, and Hxt4 transporters using quantitative real-time PCR 
(qRT-PCR) with specific primers, as we described previously (Roy 
et al., 2013). As mentioned, expression of HXT1 and HXT3 genes 
is induced by high glucose, whereas that of HXT2 and HXT4 genes 
is induced by low glucose (Figure 1D; see controls). However, 
expression of all four HXT genes was inhibited by MG in a dose-
dependent manner, and >50% inhibition was achieved at a 10 mM 
concentration of MG (Figure 1D).
Methylglyoxal decreases cell-surface levels of the Rgt2 
and Snf3 glucose sensors
Rgt2 and Snf3 sense different levels of extracellular glucose and 
function differently. Rgt2 is a low-affinity glucose sensor required for 
induction of HXT1 by high glucose, whereas Snf3 is a high-affinity 
sensor needed for the expression of HXT2 and HXT4 in response to 
low levels of glucose (Ozcan et al., 1998; Ozcan and Johnston, 
1996). Thus a yeast strain lacking these genes (rgt2Δsnf3Δ) grows 
poorly on a glucose or raffinose (as low-glucose concentration) me-
dium (Ozcan et al., 1996a). Given that MG seems to inhibit glucose 
utilization by yeast, we examined whether it inactivates the Rgt2 and 
Snf3 glucose sensors. Expression of Rgt2 in the rgt2snf3 double mu-
tant restored growth in glucose medium but not in glucose medium 
containing 10 mM MG. Similarly, Snf3 expression complemented 
the growth defect of the rgt2Δsnf3Δ strain in raffinose medium but 
not in raffinose medium containing 10 mM MG (Figure 2A). Thus 
MG seems to decrease cell-surface levels of the glucose sensors.
The stability of the glucose sensors is correlated well with their 
respective affinities; that is, Rgt2 remains stable at the plasma mem-
brane only in high-glucose-grown yeast cells; by contrast, this holds 
for Snf3 in yeast cells grown in low-glucose medium (Roy and Kim, 
2014). Fluorescence microscopy and Western blot analysis con-
firmed that GFP-Rgt2 is stable in cells grown in high-glucose me-
dium and endocytosed and subsequently degraded in the vacuole 
when cells are starved of glucose and that, by contrast, GFP-Snf3 is 
stable in cells in low-glucose medium and down-regulated when 
cells are exposed to high-glucose or glucose-free medium (Figure 2, 
B and C). Expression of the SNF3 gene is repressed about fivefold 
by high levels of glucose, whereas the RGT2 gene is expressed 
constitutively, being neither repressed nor induced by glucose 
Lagunas, 1979). Because energy generation by fermentation of glu-
cose is inefficient, yeast cells vigorously metabolize glucose by en-
hancing the rate-limiting step of glucose metabolism: its transport 
(Johnston and Kim, 2005; Kim et al., 2013; Rolland et al., 2001). 
Yeast cells have learned how to sense the amount of glucose that is 
available and respond by expressing the most appropriate of its 17 
glucose transporters (HXTs). They do this through a signal transduc-
tion pathway that begins at the cell surface with the Rgt2 and Snf3 
glucose sensors and ends in the nucleus with the Rgt1 transcription 
factor, which regulates expression of genes encoding glucose trans-
porters (Kim et al., 2013).
Expression of HXT genes is repressed by the Rgt1 DNA–binding 
repressor in the absence of glucose (Ozcan et al., 1996b). Rgt1 does 
this by recruiting the HXT corepressors Mth1 and Std1 and the gen-
eral corepressor complex Ssn6-Tup1 to the HXT promoters (Schmidt 
et al., 1999; Kim et al., 2003, 2006; Kim, 2009; Lakshmanan et al., 
2003). When glucose is added to the glucose-starved cells, Mth1 
and Std1 are phosphorylated by the plasma membrane–tethered 
casein kinases Yck1 and Yck2 (YckI), ubiquitinated by the SCF-Grr1 
ubiquitin-protein ligase, and subsequently degraded by the 26S 
proteasome (Flick et al., 2003; Moriya and Johnston, 2004). This en-
ables protein kinase A to access and phosphorylate Rgt1, resulting 
in a disruption of the Rgt1 repressor complex and consequently in 
derepression of HXT genes (Kim and Johnston, 2006; Palomino 
et al., 2006; Jouandot et al., 2011; Roy et al., 2013, 2014). It is un-
clear how an intracellular signal that induces expression of HXT 
genes is generated. However, YckI appears to be coupled to the 
cell-surface glucose sensors Rgt2 and Snf3, leading to the current 
view that glucose binding to the Rgt2 and Snf3 glucose sensors 
causes them to activate YckI, which phosphorylates Mth1 and Std1, 
which are bound to the C-terminal cytoplasmic tails of the sensors 
(Moriya and Johnston, 2004; Johnston and Kim, 2005).
Extracellular glucose is sensed by Rgt2 and Snf3 at the plasma 
membrane. These proteins are structurally similar to the Hxt glucose 
transporters but seem to have lost the ability to transport glucose 
inside the cell (Ozcan et al., 1996a). They function instead as recep-
tors that monitor extracellular glucose. A dominant mutation in the 
glucose sensors (R231K in Rgt2 and R229K in Snf3) leads to the 
constitutive expression of HXT genes even in the absence of glu-
cose, possibly converting the receptors into their glucose-bound 
form (Ozcan et al., 1996a; Pasula et al., 2007). Thus it has been 
proposed that glucose signaling by Rgt2 and Snf3 is a receptor-
mediated process, similar to hormone signaling in mammalian cells 
(Ozcan and Johnston, 1999; Johnston and Kim, 2005).
We recently reported that the glucose sensors are stable in cells 
grown in glucose but endocytosed and degraded in the vacuole 
when cells are starved of glucose (Roy and Kim, 2014). Of interest, it 
was shown that constitutively active, signaling mutants of glucose 
sensors are resistant to endocytosis, whereas signaling-defective 
sensors are constitutively targeted for degradation. Thus the stability 
of the glucose sensors may be correlated with their affinity for glu-
cose. In this article, we give evidence that MG induces endocytosis 
and degradation of the glucose sensors to inhibit expression of the 
HXT genes and consequently attenuate glycolysis. We also discuss 
the possible mechanisms by which MG regulates the stability of the 
glucose sensors and the evaluation of MG as a glycolytic inhibitor.
RESULTS
Methylglyoxal inhibits expression of the yeast glucose 
transporter genes (HXTs)
S. cerevisiae can use glucose efficiently over a broad range of con-
centrations. Accordingly, yeast cells have many different glucose 
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with the 3x hemagglutinin (HA) epitope (27 amino acids), from their 
own promoters. The results showed that the glucose sensor proteins 
are degraded by MG in a concentration-dependent manner, and 
>50% of degradation was achieved at 10 mM MG (Figure 3A). Next 
we performed qRT-PCR of RGT2 and SNF3 genes in yeast cells 
treated or not with MG and found that MG does not significantly 
affect expression of either RGT2 or SNF3 (Figure 3B). Thus the dis-
appearance of Rgt2-HA and Snf3-HA in response to MG treatment 
is due to degradation but not to transcriptional repression, and this 
was further confirmed by fluorescence microscopy of yeast cells ex-
pressing GFP-Rgt2 and GFP-Snf3 (Figure 3, C and D). We also ob-
served that the amounts of immunodetected Rgt2-HA and Snf3-HA 
were reduced by ∼50% within 100 min after yeast cells were treated 
with 10 mM MG (Figure 3E).
Methylglyoxal induces endocytosis of the Rgt2 
and Snf3 glucose sensors
Given that Rgt2 and Snf3 are inactivated by endocytosis, we exam-
ined whether MG-induced inactivation of the glucose sensors is due 
to endocytosis, followed by degradation in the vacuole. Our results 
(Ozcan et al., 1996a). We interrupted glucose regulation of expres-
sion of glucose sensor genes (SNF3 in particular) by replacing their 
promoters with the promoter of MET25, which is not regulated by 
glucose (Kim et al., 2006; Pasula et al., 2007). Therefore changes of 
the GFP-Rgt2 and GFP-Snf3 levels in response to different glucose 
concentrations might be due not to transcriptional repression but to 
posttranslational regulation. We observed that GFP-Rgt2 and GFP-
Snf3 are removed from the plasma membrane and degraded in the 
vacuole in response to MG (Figure 2D). These results suggest that 
MG inhibits expression of HXT genes by decreasing cell-surface lev-
els of the Rgt2 and Snf3 glucose sensors.
Methylglyoxal causes degradation of the Rgt2 and Snf3 
glucose sensors
To further study MG-induced inactivation of the glucose sensors, we 
conducted Western blot analysis of Rgt2 and Snf3 in the plasma 
membrane fractions of yeast cells treated with different concentra-
tions of MG. Because there is a possibility that the green fluorescent 
protein (GFP) moiety of GFP-fused Rgt2 and Snf3 affects their MG-
induced degradation, we expressed the glucose sensors, tagged 
FIGURE 1: Methylglyoxal inhibits expression of the HXT genes. (A) Schematic representation of MG metabolism 
pathways. MG is produced as a by-product of glycolysis by degradation of the triose phosphates DHAP and G3P. It is 
then metabolized into d-lactate by glyoxalase systems (GLO1 and GLO2) or 1,2-propanediol by aldolase reductase 
(GRE3). (B) Yeast cells (WT) were spotted on YP plates containing 2% glucose (Glucose) or 2% raffinose (Raffinose) 
supplemented with different concentrations of MG as shown. The first spot of each row represents a count of 5 × 107 
cells/ml, which is diluted 1:10 for each spot thereafter. The plates were incubated for 2 d and photographed. (C) This 
figure has been removed by agreement of the authors and the journal’s Editorial Board because it contained incorrect 
data. (D) qRT-PCR analysis of mRNA expressions of HXT1, HXT2, HXT3, and HXT4 genes. mRNA was isolated from yeast 
cells (WT) grown in either 2% glucose (to quantify HXT1 and HXT3 gene expressions) or 2% raffinose (to quantify HXT2 
and HXT4 gene expressions) containing the indicated amounts of MG. The data are averages of three independent 
experiments, with error bars showing mean ± SD. *p < 0.05 and **p < 0.001.
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wild-type cells but not in doa4Δ or rsp5-1ts mutant cells (Figure 5, 
A and B). Thus Rgt2 and Snf3 accumulated in the plasma mem-
brane of the yeast mutants, regardless of the treatment of MG 
(Figure 5, C and D). We previously identified Lys-637 and Lys-657 
of Rgt2 as putative ubiquitination sites (Roy and Kim, 2014). The 
Rgt2K637A,K657A mutant is resistant to MG-induced degradation 
(Figure 5E), and its expression allows yeast cells to grow on MG-
containing medium (Figure 5F). These results suggest that MG in-
duces Rsp5-dependent endocytosis and vacuolar targeting of the 
glucose sensors.
Glo1 plays an essential role in the growth of yeast 
in the presence of methylglyoxal
MG, both exogenously supplied and endogenously produced via 
glycolysis, is detoxified by the glyoxalase system. In yeast, MG is 
metabolized by two pathways (Figure 1A): the glutathione-depen-
dent glyoxalase pathway and the NADPH-dependent aldose re-
ductase pathway (Aguilera and Prieto, 2001; Vander Jagt et al., 
2001; Chen et al., 2003). The glyoxalase pathway consists of the 
enzymes glyoxalase I (Glo1), which catalyzes the formation of S-d-
lactoylglutathione from methylglyoxal, and reduced glutathione 
(GSH) and glyoxalase II (Glo2), which recycles GSH and releases 
d-lactate (Martins et al., 2001a,b). Aldose reductase, encoded by 
showed that MG treatment decreases the protein levels of Rgt2-HA 
and Snf3-HA in wild-type yeast cells but not in yeast cells lacking 
End3, a protein involved in the internalization step of endocytosis, 
which suggests that MG induces endocytosis of Rgt2 and Snf3 
(Figure 4, A and C). This was confirmed by confocal microscopy 
showing that GFP-Rgt2 and GFP-Snf3 are removed from the plasma 
membrane and targeted to the vacuole for degradation in response 
to MG in wild-type yeast cells but not in the end3Δ mutant cells 
(Figure 4, B and D).
Methylglyoxal may promote Rsp5-dependent degradation 
of the Rgt2 and Snf3 glucose sensors
Ubiquitination is a common signal for endocytosis and subsequent 
degradation of plasma membrane proteins (Hicke and Dunn, 
2003). A number of yeast nutrient transporters are ubiquitinated 
by the ubiquitin ligase Rsp5, and this process is affected by the 
ubiquitin isopeptidase Doa4, which is required for recycling ubiq-
uitin from ubiquitinated substrates (Springael and Andre, 1998; 
Amerik et al., 2000; Rotin et al., 2000). Rsp5 is involved in degra-
dation of the Rgt2 glucose sensor (Roy and Kim, 2014). Thus we 
examined the role of Rsp5 in the MG-induced endocytosis and 
degradation of glucose sensors. Western blot analysis showed that 
Rgt2-HA and Snf3-HA levels are decreased in response to MG in 
FIGURE 2: MG inactivates the yeast glucose sensors Rgt2 and Snf3. (A) Yeast cells (rgt2∆snf3∆) expressing empty 
vector, Rgt2-HA (left) or Snf3-HA (right panel) were streaked on SC plates containing 2% glucose (Glucose) or 2% 
raffinose (Raffinose), supplemented with or without 10 mM MG. The plates were incubated for 2 d and photographed. 
(B) Yeast cells (WT) expressing GFP-Rgt2 or GFP-Snf3 were grown in SC medium containing 2% galactose (Gal) until mid 
log phase (A600 nm = 1.2–1.5), and equal amounts of cells were shifted to SC medium containing 2% raffinose (Raf) or 2% 
glucose (Glu). The distributions of the GFP fluorescence were analyzed by confocal microscopy. FM4-64 dye was used 
to visualize vacuoles. (C) Western blot analysis of GFP-Rgt2 and GFP-Snf3 levels at the plasma membrane. Yeast cells 
(WT) expressing GFP-Rgt2 or GFP-Snf3 were grown as described in B. Membrane fractions were analyzed using 
anti-GFP and anti-actin antibodies. (D) Yeast cells (WT) expressing GFP-Rgt2 or GFP-Snf3 were grown in SC medium 
containing 2% glucose (GFP-Rgt2) or 2% raffinose (GFP-Snf3) until mid log phase and treated with 10 mM MG for 2 h. 
The distributions of the GFP fluorescence were analyzed by confocal microscopy. Actin served as a loading control in C.
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expression in response to glucose. Several lines of evidence indicate 
that MG induces endocytosis and degradation of the glucose sensors: 
1) they are removed from the plasma membrane and targeted to the 
vacuole for degradation in response to MG (Figures 2 and 3); 2) MG-
induced degradation of these sensor proteins requires End3, Doa4, or 
active Rsp5 (Figures 4 and 5); and 3) glucose sensors with mutations 
at the putative ubiquitination sites are resistant to MG-induced endo-
cytosis (Figure 5). The Rgt2 and Snf3 glucose sensors are essential for 
yeast cells to grow on glucose as sole carbon source. Our findings 
suggest that MG inhibits the growth of glucose-fermenting yeast cells 
by promoting degradation of the glucose sensors.
It is unknown how MG induces endocytosis of the glucose sen-
sors, but our recent findings might provide a clue to the role of 
MG in regulation of these sensor proteins (Roy and Kim, 2014). 
The glucose sensors undergo a conformational change from an 
Gre3, catalyzes the two-step reduction of methylglyoxal to 1,2-pro-
panediol, with acetol (hydroxyacetone) as an intermediate (Chen 
et al., 2003). Thus the glo1Δ mutant was more sensitive to MG 
than the wild-type strain (Figure 6A), as reported previously (Maeta 
et al., 2005). Of greater importance, the Rgt2 and Snf3 glucose 
sensors are more sensitive to exogenous MG in the glo1∆ mutant, 
where intracellular MG is not efficiently metabolized, than in wild-
type yeast, consistent with the result that the glucose sensors are 
primary targets of MG (Figure 6, B and C).
DISCUSSION
MG is a cytotoxic metabolite formed as a by-product of glycolysis, but 
its targets are largely unknown. In this study, we found that MG inhibits 
expression of the HXT glucose transporter genes by inactivating the 
yeast glucose sensors Rgt2 and Snf3, which generate a signal for HXT 
FIGURE 3: MG induces posttranslational down-regulation of Rgt2 and Snf3 in a dose-dependent manner. (A) Western 
blot analysis of Rgt2-HA (top) and Snf3-HA (bottom) levels at the plasma membrane. Yeast cells (WT) expressing 
Rgt2-HA or Snf3-HA were grown in SC-2% glucose or SC-2% raffinose medium, respectively, until mid log phase 
(A600 nm = 1.2–1.5), and equal amounts of cells were shifted to SC medium containing the indicated concentrations of 
MG for 2 h. Membrane fractions were analyzed using anti-HA and anti-Pma1 antibodies. (B) qRT-PCR analysis of mRNA 
expressions (mRNA, closed circles) of RGT2 (top) and SNF3 (bottom) in yeast cells grown as described in A; 
densitometric quantification of the intensities of each of the bands on the blot in A (protein, open circles). (C) Yeast cells 
(WT) expressing GFP-Rgt2 or GFP-Snf3 were grown as described in A, and the distributions of the GFP fluorescence 
were analyzed by confocal microscopy. (D) Quantification of the GFP fluorescence intensities of plasma membrane (PM) 
from the cells depicted in C; box-and-whiskers plot (n >150). The horizontal midline represents the median; the box is 
bounded by the upper and lower quartiles; the whiskers denote the maximum and minimum fluorescence intensities 
with 5th and 95th percentiles. (E) Yeast cells (WT) expressing Rgt2-HA or Snf3-HA were grown in SC-2% glucose or 
SC-2% raffinose medium, respectively, until mid log phase (A600 nm = 1.2–1.5) and shifted to SC medium containing 
10 mM MG for the times as indicated. Membrane fractions were immunoblotted with anti-HA and anti-Pma1 antibodies 
(left), and half-lives of Rgt2-HA and Snf3-HA were calculated as described in Materials and Methods (right). Pma1 served 
as a loading control in A and E.
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glucose-induced conformational change of 
the glucose sensors, keeping them in the 
inactive state and thereby targeting them 
to the vacuole. Our evidence shows that 
endocytosis of these proteins requires the 
Rsp5 ubiquitin ligase. Thus it is conceivable 
that MG directly or indirectly modifies Rgt2 
and Snf3, making them accessible to Rsp5.
In yeast, MG enters the cell via the Fps1 
plasma membrane channel (Mollapour and 
Piper, 2007), and it is detoxified by the gly-
oxalase system (e.g., Glo1; Figure 1A). Our 
data show that the inhibitory effect of MG 
on the glucose sensors is greatly enhanced 
in the glo1Δ mutant, where MG accumu-
lates (Figure 6). This suggests that degrada-
tion of Rgt2 and Snf3 is stimulated by intra-
cellular MG. We cannot exclude the 
possibility that MG inhibits binding of glu-
cose to the glucose sensors, keeping them 
in glucose-unbound form and vulnerable to 
degradation. However, this hypothesis is 
less tenable, in that the stability of Rgt2 and 
Snf3 is regulated by intracellular MG. In 
summary, our results suggest that MG pre-
vents glucose-fermenting yeast cells from 
using glucose as sole carbon source by in-
hibiting expression of the HXT genes and 
thus identify MG as a glycolytic inhibitor. 
Intracellular MG concentrations are ele-
vated under conditions of increased glyco-
lytic flux, such as aerobic glycolysis associ-
ated with malignant transformation (Kawase 
et al., 1996). These observations suggest 
that exogenous supply of MG in combina-
tion with pharmacological inhibitors of Glo1 
may be an effective way to target cancer 
cells, which heavily rely on glycolysis for 
energy.
MATERIALS AND METHODS
Yeast strains and growth conditions
The S. cerevisiae strains used in this study 
are listed in Table 1. Cells were grown in YP 
(2% bactopeptone, 1% yeast extract) and 
SC (synthetic yeast nitrogen base medium 
containing 0.17% yeast nitrogen base and 
0.5% ammonium sulfate) media supple-
mented with appropriate amino acids and 
carbon sources. The plasmids used in this 
study are listed in Table 2.
Yeast membrane preparation, Western blotting, and protein 
half-life measurement
Membrane-enriched fractions were essentially prepared as de-
scribed previously (Galan et al., 1996). Briefly, cells expressing 
Rgt2-HA, Snf3-HA, Rgt2K637A K657A-HA, GFP-Rgt2, and GFP-Snf3 
were cultured in 200-ml conical flasks containing 50 ml of SC 
medium to mid log phase (A600 nm = 1.2–1.5), treated with differ-
ent concentrations of MG (0–20 mM), and further incubated for 
0–120 min, as indicated in the figures. The cells were harvested 
and washed with phosphate buffer, pH 7.4, containing 10 mM 
inactive to an active state upon glucose binding (Thevelein and 
Voordeckers, 2009). The active form (glucose bound) of these pro-
teins localizes and functions at the plasma membrane, whereas the 
inactive ones (glucose unbound) are targeted to the vacuole for 
degradation. This notion is supported by the findings that Rgt2 
and Snf3 are stabilized at the plasma membrane only when the 
extracellular glucose concentration is in the range of their respec-
tive affinities and that constitutively active mutants of Rgt2 and 
Snf3 sensors are not down-regulated even when glucose is absent 
(Roy and Kim, 2014). We hypothesize that MG may inhibit the 
FIGURE 4: MG induces endocytosis of Rgt2 and Snf3. (A) Western blot analysis of Rgt2-HA 
levels at the plasma membrane. Yeast cells (WT and end3∆) expressing Rgt2-HA were grown as 
described in Figure 3A. Membrane fractions were immunoblotted with anti-HA antibody (top). 
The intensities of each band on the blots were quantified by densitometric scanning (bottom; 
*p < 0.05 and **p < 0.001). (B) Yeast cells (WT and end3∆) expressing GFP-Rgt2 were grown as 
described in Figure 2D. Confocal microscopy images (top) and quantifications of the GFP 
fluorescence intensities (bottom) as described in Figure 3D. (C) Western blot analysis of Snf3-HA 
levels at the plasma membrane was performed as described in A. Membrane fractions were 
immunoblotted with anti-HA antibody (top). The intensities of each band on the blots were 
quantified by densitometric scanning (bottom). (D) Confocal microscopy analysis of localization 
of GFP-Snf3 was carried out as described in B.
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10% glycerol, 2% SDS, 5% β-mercaptoethanol). The proteins 
were resolved by 8% SDS–PAGE and transferred to polyvinyli-
dene fluoride membranes (Millipore, Billerica, MA), and the 
membranes were incubated with appropriate antibodies (anti-
HA, anti-GFP, anti-actin, or anti-Pma1 antibody; Santa Cruz Bio-
technology, Santa Cruz, CA) in TBST buffer (10 mM Tris-Cl, pH 
7.5, 150 mM NaCl, 0.1% Tween 20), and the immunoreactive 
bands were visualized by enhanced chemiluminescence (Pierce, 
Rockford, IL). The half-lives of Rgt2-HA and Snf3-HA were mea-
sured as described previously (Belle et al., 2006). Briefly, the 
sodium azide, and the cell pellets were resuspended in ice-cold 
membrane isolation buffer (100 mM Tris-Cl, pH 8, 150 mM NaCl, 
5 mM EDTA) containing 10 mM sodium azide and protease and 
phosphatase inhibitors and vortexed with acid-washed glass 
beads. The samples were diluted with the same buffer, and cell 
debris was removed by centrifugation. The membrane-enriched 
fractions were collected by centrifuging the samples at 12,000 
rpm for 40 min at 4°C. The proteins were precipitated with 10% 
trichloroacetic acid, neutralized with 20 μl of 1 M Tris base, and 
finally dissolved in 80 μl of SDS buffer (50 mM Tris-Cl, pH 6.8, 
FIGURE 5: Rsp5 ubiquitin ligase is required for MG-induced vacuolar targeting and degradation of Rgt2 and Snf3. 
(A) Western blot analysis of Rgt2-HA levels at the plasma membrane. Yeast cells (WT, doa4∆ and rsp5-1) expressing 
Rgt2-HA were grown as described in Figure 2D. Membrane fractions were immunoblotted with anti-HA and anti-Pma1 
antibodies. (B) Western blot analysis of Snf3-HA levels at the plasma membrane was performed as described in A. 
(C) Yeast cells (WT, doa4∆ and rsp5-1) expressing GFP-Rgt2 or GFP-Snf3 were grown as described in Figure 2D. The 
distributions of the GFP intensities were analyzed by confocal microscopy. (D) Quantification of the GFP fluorescence 
intensities from the cells depicted in C; box-and-whiskers plot (n > 150). (E) Western blot analysis of Rgt2-HA or 
Rgt2K637A K657A-HA levels at the plasma membrane. Yeast cells (rgt2∆snf3∆) expressing Rgt2-HA or Rgt2K637A K657A-HA 
were grown in SC-2% glucose medium until mid log phase (A600 nm = 1.2–1.5) and shifted to SC medium containing 
10 mM MG for 2 h. Membrane fractions were immunoblotted with anti-HA and anti-Pma1 antibodies. (F) Yeast cells 
(rgt2∆snf3∆) expressing Rgt2-HA or Rgt2K637A K657A-HA were streaked on YP plates containing 2% glucose (Glucose), 
supplemented with or without 10 mM MG. The plates were incubated for 2 d and photographed. Pma1 served as a 
loading control in A, B, and E.
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qRT-PCR
Total RNA was extracted by an RNeasy 
minikit (Qiagen, Valencia, CA) following the 
manufacturer’s protocol, and 2 μg of total 
RNA was converted to cDNA by qScript 
cDNA supermix (Quanta Biosciences, 
Gaithersburg, MD). cDNA was analyzed by 
qRT-PCR2 using SsoFast Evagreen reagent 
(Bio-Rad, Hercules, CA) in a CFX96 Real-
Time Thermal Cycler (Bio-Rad). ACT1 was 
used as an internal control to normalize ex-
pression of HXT1-4 RGT2, and SNF3 
genes. All of the quantification data shown 
are the averages of three independent ex-
periments, with error bars representing SD. 
Statistical significance was calculated by 
Student’s t test using SigmaPlot software. 
*p < 0.05 and **p < 0.001 as compared 
with control.
Fluorescence microscopy 
and quantification
The GFP-tagged glucose sensors Rgt2 and 
Snf3 were imaged using a spinning-disk 
confocal microscope (Carl Zeiss) fitted with 
an Apo 150× glycerol objective (numerical 
aperture, 1.35). The cells were grown in SC 
medium supplemented with 2% galactose, 
2% glucose, or 2% raffinose to mid log 
phase (A600 nm = 1.2–1.5), and MG was 
added to a final concentration of 0–20 mM. 
The cells were further incubated for 
0–120 min, as indicated in the figures, be-
fore imaging. Cells were plated onto glass-
bottom dishes (Greiner Bio One, Monroe, 
NC) and allowed to settle for 5 min before 
imaging. All images from an experiment 
were captured with identical imaging pa-
rameters and equivalently adjusted using 
Adobe Photoshop software. To visualize 
vacuoles, cells were first incubated with 
1.6 μM FM 4-64 dye for 30 min and then 
pelleted and resuspended in fresh me-
dium without FM 4-64. The images were 
captured using a Texas red filter. The fluo-
rescence intensities of GFP-Rgt2 and GFP-
Snf3 were quantified using ImageJ, ver-
sion 1.4r, software. For the quantification 
of fluorescence at the cell surface, the 
mean pixel intensities of the plasma mem-
brane in each of at least 150 cells were 
measured, and the mean background 
pixel intensities were subtracted. The dis-
tributions of mean pixel intensities (in arbi-
trary units) are presented as box-and-whiskers plots generated by 
SigmaPlot, version 12, software. For all bar plots, each mean 
value represents the average for a minimum of three independent 
experiments. SDs were calculated and are shown as error bars. 
Statistical significance was calculated by Student’s t test using 
SigmaPlot software. *p < 0.05 and **p < 0.001 as compared with 
control.
band intensities were quantified by densitometry using ImageJ, 
version 1.4r, software (National Institutes of Health, Bethesda, 
MD) and normalized with the intensities of Pma1. The numbers 
obtained from the control samples (without MG treatment) were 
converted to 100, and all the values were plotted on a semiloga-
rithmic graph against time and further fitted to an exponential 
line.
FIGURE 6: Inactivation of GLO1 gene causes rapid down-regulation of Rgt2 and Snf3. 
(A) Yeast cells (WT, glo1∆ and gre3∆) were spotted on YP plates containing 2% glucose 
(Glucose) or 2% raffinose (Raffinose) supplemented with the indicated concentrations 
of MG, as described in Figure 1B. The plates were incubated for the indicated time and 
photographed. (B) Western blot analysis of Rgt2-HA at the plasma membrane. Yeast cells 
(WT and glo1∆) expressing Rgt2-HA were grown in SC medium containing 2% glucose until 
mid log phase and treated with the indicated concentrations of MG for 2 h. Membrane 
fractions were immunoblotted with anti-HA and anti-Pma1 antibodies (left). (C) Western blot 
analysis of Snf3-HA at the plasma membrane. Yeast cells (WT and glo1∆) expressing Snf3-HA 
were grown in SC medium containing 2% raffinose until mid log phase and treated with the 
indicated concentrations of MG for 2 h. Membrane fractions were immunoblotted with 
anti-HA and anti-Pma1 antibodies (left). The intensities of each band on the blots in B and 
C were quantified by densitometric scanning (right). Pma1 served as a loading control in B 
and C.
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Strain Genotype Source
BY4741 Mata his3Δ1 leu2Δ0 ura3Δ0 
met15Δ
Kaniak et al. (2004) 
YM 6870 MATa his3∆1 leu2∆0 
ura3∆0 met15∆0 LYS2 
rgt2::kanMX::natMX 
snf3::kanMX
Kaniak et al. (2004)
KFY 122 Matα his3Δ1 leu2Δ0 ura3Δ0 
doa4::KanMX
Roy and Kim (2014)
KFY 123 Mata his3Δ1 leu2Δ0 ura3Δ0 
RSP5
Liu et al. (2007) 
KFY 124 Mata his3Δ1 leu2Δ0 ura3Δ0 
rsp5-1/smm1
Liu et al. (2007)
KFY 127 Matα his3Δ1 leu2Δ0 ura3Δ0 
end3::KanMX
Roy and Kim (2014)
KFY 165 Matα his3Δ1 leu2Δ0 ura3Δ0 
glo1::KanMX
This study
KFY 166 Matα his3Δ1 leu2Δ0 ura3Δ0 
gre3::KanMX
This study
TABLE 1: Yeast strains used in this study.
Plasmid 
name Description Source
KFP69 pAD80, 3x-HA-CYC1 
terminator, Leu2, 2 μ
Kim (2009)
JKP251 pAD80-PRGT2-Rgt2-3xHA Roy and Kim (2014)
JKP293 pUG34-PMET25-GFP-Rgt2, His3, 
CEN
Roy and Kim (2014)
JKP298 pAD80-PSNF3-Snf3-3xHA Roy and Kim (2014)
JKP308 pAD80-PRGT2-Rgt2 (K637A, 
K657A)-3xHA
Roy and Kim (2014)
JKP309 pUG34-PMET25-GFP-Snf3, His3, 
CEN
Roy and Kim (2014)
TABLE 2: Plasmids used in this study.
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